Rosa & Co. announces the publication of an article using virtual patients and multiomics to predict efficacy of a cutaneous lupus therapy.

Rosa & Co. announced today the publication of an article titled, "Virtual patients inspired by multiomics predict the efficacy of an anti-IFNα mAb in cutaneous lupus." Rosa & Co. co-published the article with Servier, Research and Development and GENYO Center for Genomics and Oncological research in iScience on January 6, 2025.  To read the article: iScience journal article link.